Cookie Consent by Free Privacy Policy Generator Update cookies preferences

Session 20

OESO-SEMPIRE 16th World Conference | Esophagus 2024 | Strasbourg | April 23-26, 2024 | Venue: IRCAD France

<  back to Program at a glance
<  back to all the scientific sessions


Session 20: Esophageal Cancer: Squamous Cell Carcinoma

Thursday, April 25, 2:00 – 3:30 pm
Auditorium Kagame‚Äč

Introduction: Andrew Chang (USA) – Giovanni de Manzoni (Italy)
Chairs: Kiran H. Lagisetty (USA)
 – You-Sheng Mao (China) – Philippe Morel (Switzerland) 
Moderators: Russel E. White (Kenya) – Rubens A. A. Sallum (Brazil)

  1. Pathologic complete response is an equivalent outcomes metric for patients receiving either neoadjuvant chemotherapy or chemoradiation? 
  2. Active surveillance rather than resection is appropriate for patients with esophageal SCC who demonstrate complete clinical response after completing neoadjuvant therapy? – Kiran H. Lagisetty (USA)
  3. Indications for open esophagectomy? – Arnulf Hölscher (Germany)
  4. Are there still surgical indications for proximal esophageal cancer? – Rishindra M. Reddy (USA) 
  5. Technique, indications and results for transcervical esophagectomy – Bastiaan Klarenbeek (Netherlands)
  6. The usefulness of a bilateral trans-cervical pneumomediastinal approach for mediastinoscopic radical esophagectomy – Yutaka Tokairin (Japan)
  7. What is the best way to treat anastomotic leakage: cervical anastomosis? – Jon O. Wee (USA)